Lynx1 Capital Management LP

10% owner, Korro Bio, Inc.; 10% owner, TScan Therapeutics, Inc.; 10% owner, Neuphoria Therapeutics Inc.; 10% owner, Cullinan Therapeutics, Inc.

Bought, 12 months

$1.1M

Sold, 12 months

$0.0M

Companies

Latest trade

Oct 26, 2026

Companies

Korro Bio, Inc.10% owner +$1.0M TScan Therapeutics, Inc.10% owner +$0.1M Neuphoria Therapeutics Inc.10% owner +$3.3M Cullinan Therapeutics, Inc.10% owner +$11.9M

Trades

KRRO Bought 25,124 shares at $11.75 $0.3M Oct 26

KRRO Bought 2,510 shares at $12.11 $0.0M Oct 23

KRRO Bought 52,175 shares at $10.72 $0.6M Oct 22

KRRO Bought 1,462 shares at $13.19 $0.0M Aug 10

KRRO Bought 5,222 shares at $11.40 $0.1M Aug 6

TCRX Bought 6,232 shares at $0.90 $0.0M Dec 23

TCRX Bought 75,500 shares at $0.90 $0.1M Dec 22

TCRX Bought 80,069 shares at $0.90 $0.1M Dec 19

NEUP Bought 639,110 shares at $5.14 $3.3M Oct 21

CGEM Bought 32,217 shares at $7.84 $0.3M Oct 17

CGEM Bought 150,000 shares at $8.86 $1.3M Oct 16

CGEM Bought 51,500 shares at $7.94 $0.4M Oct 15

CGEM Bought 15,032 shares at $7.59 $0.1M Oct 14

CGEM Bought 277,298 shares at $7.36 $2.0M Oct 10

CGEM Bought 626,043 shares at $6.70 $4.2M Oct 9

CGEM Bought 556,300 shares at $6.46 $3.6M Oct 8

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.